Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile

Introduction: Only a minority of patients with platinum refractory head and neck squamous cell carcinoma (PR/HNSCC) gain some lasting benefit from immunotherapy. Methods: The combined role of the comprehensive genomic (through the FoundationOne Cdx test) and immune profiles of 10 PR/HNSCC patients t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mezi, Silvia, Pomati, Giulia, Zizzari, Ilaria Grazia, Di Filippo, Alessandra, Cerbelli, Bruna, Cirillo, Alessio, Fiscon, Giulia, Amirhassankhani, Sasan, Valentini, Valentino, De Vincentiis, Marco, Corsi, Alessandro, Di Gioia, Cira, Tombolini, Vincenzo, Della Rocca, Carlo, Polimeni, Antonella, Nuti, Marianna, Marchetti, Paolo, Botticelli, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687656/
https://www.ncbi.nlm.nih.gov/pubmed/36359251
http://dx.doi.org/10.3390/biomedicines10112732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687656/
https://www.ncbi.nlm.nih.gov/pubmed/36359251
http://dx.doi.org/10.3390/biomedicines10112732

Ejemplares similares